Gazi University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Karachi Pakistan (1945)

Organization Overview

First Clinical Trial
2006
NCT00934154
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Didem Sakaryali | Gazi Univercity | Gazi Üniversitesi Sağlık Bilimleri Fakültesi | Gazi University | Gazi University, Ankara, Turkey | Gazi University, Faculty of Dentistry, Department of Pediatric Dentistry | Gazi University Faculty of Health Sciences | Gazi University, Faculty of Health Sciences | Gazi University, Faculty of Health Sciences, Physiotherapy and Rehabilitation | Gazi University, Faculty of Medicine, Child and Adolescent Psychiatry | Gazi University Faculty of Medicine, Department of Physical Medicine and Rehabilitation | Gazi University, Faculty of Medicine, Medical Biochemistry | Gazi University (formerly) | Gazi University Medical Faculty | Gazi Universty | Melek Volkan Yazici

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Gingival Recession (Phase 2)

Kidney Diseases (Phase 3)

Multiple Myeloma (Phase 3)

Nausea (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Postoperative Nausea and Vomiting (Phase 3)

Rectal Diseases (Phase 4)

Renal Insufficiency, Chronic (Phase 3)

Shock (Phase 2)

Sinusitis (Phase 4)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 44
  • # of Trial APIs: 13